Home » Stocks » AMPE

Ampio Pharmaceuticals, Inc. (AMPE)

Stock Price: $0.844 USD 0.004 (0.44%)
Updated November 24, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 156.13M
Revenue (ttm) n/a
Net Income (ttm) -12.30M
Shares Out 185.06M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 24
Last Price $0.844
Previous Close $0.840
Change ($) 0.004
Change (%) 0.44%
Day's Open 0.831
Day's Range 0.801 - 0.857
Day's Volume 873,170
52-Week Range 0.310 - 1.390

More Stats

Market Cap 156.13M
Enterprise Value 147.77M
Earnings Date (est) May 13, 2021
Ex-Dividend Date n/a
Shares Outstanding 185.06M
Float 170.32M
EPS (basic) -0.07
EPS (diluted) -0.11
FCF / Share -0.09
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 19.20M
Short Ratio 16.48
Short % of Float 11.27%
Beta 1.80
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 14.85
Revenue n/a
Operating Income -19.07M
Net Income -12.30M
Free Cash Flow -16.66M
Net Cash 8.36M
Net Cash / Share 0.05
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -75.65%
ROE -165.48%
ROIC -269.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.00*
Low
4.00
Current: $0.844
High
4.00
Target: 4.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue------0.050.050.02-
Revenue Growth------0%166.67%--
Gross Profit------0.050.050.02-
Operating Income-18.58-11.18-15.68-17.08-24.17-31.45-24.02-11.82-11.13-6.70
Net Income-13.6333.99-51.89-19.16-24.11-31.31-24.01-11.59-18.36-8.05
Shares Outstanding13173.3665.3053.7751.9950.2338.2933.9826.0116.29
Earnings Per Share-0.14-0.12-0.79-0.36-0.62-0.76-0.63-0.34-0.71-0.49
Operating Cash Flow-15.38-12.14-11.41-14.62-26.44-30.74-19.13-9.72-9.13-2.63
Capital Expenditures-0.02-0.56-0.07-0.01-0.11-8.67-1.31--0.08-
Free Cash Flow-15.41-12.70-11.48-14.63-26.55-39.41-20.44-9.72-9.22-2.63
Cash & Equivalents6.537.598.245.0516.0350.3626.3517.7011.400.67
Total Debt1.210.48-------3.14
Net Cash / Debt5.327.118.245.0516.0350.3626.3517.7011.40-2.47
Assets14.0014.0315.3113.6050.4270.2736.0225.8519.480.74
Liabilities7.568.7949.496.9612.494.812.802.021.724.75
Book Value6.445.24-34.186.6337.0066.1233.0823.8317.76-4.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Ampio Pharmaceuticals, Inc.
Country United States
Employees 23
CEO Michael E. Macaluso

Stock Information

Ticker Symbol AMPE
Stock Exchange NYSE American
Sector Healthcare
Industry Biotechnology
Unique Identifier NYSEAMERICAN: AMPE

Description

Ampio Pharmaceuticals, a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.